Work

Ruxolitinib in Combination with Dasatinib and Dexamethasone Is an Active and Well-Tolerated Chemotherapy-Sparing Oral Induction Regimen for Adults with Philadelphia Chromosome-Positive ALL: Results of a Phase I Trial

Year: 2018

Type: conference-abstract

Source: Blood

DOI: 10.1182/blood-2018-99-110537

Authors: Mark Blaine Geyer, Patrick W. Burke, Amber C. King, Michael J. Mauro, Martin S. Tallman, Ross L. Levine, Charles J. Sherr, Dan Douer, Jae H. Park

Institutions: Memorial Sloan Kettering Cancer Center, University of Michigan, St. Jude Children's Research Hospital

Language: English

Topic: Acute Lymphoblastic Leukemia research

Subfield: Public Health, Environmental and Occupational Health

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2910535166

Cites:

Cited by:

Related to: 10